0001209191-17-063687.txt : 20171204
0001209191-17-063687.hdr.sgml : 20171204
20171204202303
ACCESSION NUMBER: 0001209191-17-063687
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171130
FILED AS OF DATE: 20171204
DATE AS OF CHANGE: 20171204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Routti Jorma
CENTRAL INDEX KEY: 0001621330
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36740
FILM NUMBER: 171238466
MAIL ADDRESS:
STREET 1: C/O FIBROGEN, INC.
STREET 2: 409 ILLINOIS ST.,
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIBROGEN INC
CENTRAL INDEX KEY: 0000921299
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-978-1200
MAIL ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-11-30
0
0000921299
FIBROGEN INC
FGEN
0001621330
Routti Jorma
C/O FIBROGEN, INC.
409 ILLINOIS ST.
SAN FRANCISCO
CA
94158
1
0
0
0
Common Stock
2017-11-30
4
M
0
6000
2.90
A
133840
D
Common Stock
2017-11-30
4
S
0
6000
47.18
D
127840
D
Common Stock
2017-12-01
4
M
0
6000
2.90
A
133840
D
Common Stock
2017-12-01
4
S
0
6000
47.32
D
127840
D
Stock Option (Right to Buy)
2.90
2017-11-30
4
M
0
6000
0.00
D
2020-06-09
Common Stock
6000
6000
D
Stock Option (Right to Buy)
2.90
2017-12-01
4
M
0
6000
0.00
D
2020-06-09
Common Stock
6000
0
D
Shares sold pursuant to a 10b5-1 plan.
The shares were sold at prices ranging from $46.80 to $47.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $47.00 to $47.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price
Fully vested.
/s/ Dorothy Pacini, Attorney-in-fact
2017-12-04